How do I read and understand my Lymphoma pathology report

LymphomaMay 15, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Your Lymphoma Pathology Report

A pathology report is one of the most important documents in your lymphoma diagnosis. It describes what the pathologist (a doctor who studies tissue samples under a microscope) found in your biopsy. Let me walk you through what you'll typically see and what it means.

The Main Sections of Your Report

1. Clinical History/Indication

This section explains why the biopsy was done—for example, "evaluation of enlarged lymph node" or "suspected lymphoma."

2. Specimen Description

This describes what was biopsied. According to NCCN Guidelines for Patients, your lymphoma sample might come from:

  • Lymph node biopsy (most common) - can be done as:
    • Fine-needle aspiration (FNA) - uses a thin needle
    • Core biopsy (CB) - uses a slightly larger needle
    • Excisional biopsy - removes the entire lymph node (preferred when possible)
  • Bone marrow - a sample from inside your hip bone
  • Other tissues - spleen, liver, or other affected areas

3. Microscopic Findings

This is the detailed description of what the pathologist saw. Key things you might see:

Cell Type and Size:

  • Lymphomas are classified by the size and appearance of cancer cells
  • "Large cells" vs. "small cells" matters for diagnosis and treatment planning

Immunophenotyping Results: This is crucial information. According to NCCN Guidelines, immunophenotyping uses special antibodies to identify specific markers (proteins) on your cancer cells. You'll see results written like:

  • CD20+ (positive) = marker is present
  • CD5- (negative) = marker is absent

Example for Follicular Lymphoma: The typical pattern is CD10+, BCL2+, CD23+/-, CD43-, CD5-, CD20+, and BCL6+

These markers help your doctor:

  • Confirm the exact type of lymphoma
  • Predict how the cancer might behave
  • Guide treatment decisions

4. Genetic and Molecular Testing

According to NCCN Guidelines for Marginal Zone Lymphomas, mutation testing looks for specific DNA changes in your cancer cells. You might see results for:

Types of genetic changes:

  • Deletion - when part of a gene is missing
  • Amplification - when a gene is duplicated or increased
  • Translocation - when parts of chromosomes swap places
  • Point mutation - when a single part of a gene is changed

Why this matters: Some mutations can be targeted with specific therapies. Others may affect how your cancer responds to treatment or whether it might develop drug resistance over time.

Common mutations in lymphoma include:

  • BCL2, BCL6, MYC rearrangements
  • TP53 mutations
  • NOTCH1, SF3B1 mutations (in certain lymphoma types)

5. Diagnosis

This is the pathologist's conclusion—the specific type of lymphoma you have. Examples include:

  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Hodgkin Lymphoma
  • Others

What the Markers Tell Your Doctor

According to NCCN Guidelines, the immunophenotype (the pattern of markers) helps distinguish your lymphoma type from others. For example:

  • CD20+ is present in most B-cell lymphomas (important because many treatments target CD20)
  • CD5+ might suggest one type; CD5- suggests another
  • BCL2+ and BCL6+ help identify follicular lymphoma

Important Things to Know

Immunophenotype can change: According to NCCN Guidelines, as your cancer progresses or during treatment, the pattern of markers on your cells can shift. This is why repeat testing is sometimes done.

Mutations may develop during treatment: New drug-resistant mutations can emerge over time, which is why your doctor may recommend repeat testing if your lymphoma stops responding to treatment.

Questions to Ask Your Pathologist or Oncologist

  1. What is the exact type and subtype of lymphoma I have?
  2. What do the immunophenotyping results (the CD markers) mean for my treatment options?
  3. Were any genetic mutations found, and what do they mean?
  4. Are there any prognostic factors (things that predict how the cancer might behave) in my report?
  5. Will I need repeat biopsies or testing during my treatment?
  6. Are there any markers that make me eligible for specific targeted therapies?

Getting the Most from Your Report

  • Ask for a copy - You have the right to your [ID removed]
  • Bring it to appointments - Share it with your oncology team
  • Don't try to interpret alone - Your oncologist will explain what YOUR specific results mean for YOUR treatment plan
  • Ask for clarification - Medical terminology can be confusing; it's okay to ask questions

Next Steps

Your pathology report is the foundation for your treatment plan. Your oncologist will use these findings along with imaging tests (CT scans, PET scans) and your overall health to recommend the best approach for you.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: